Replies to post #256984 on Avid Bioservices Inc (CDMO)

[EndoTarget]

Estimated Study Completion Date: March 2016
Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)

[thealias2002]

A serious question for the board...

Many here have claimed that, had our p2 trial (which was actually a p3 designed trial) not had issues/sabotage, we could have been approved by now.

Given that trial's data reconstitution and a (hopefully) positive showing in p3, with Bavi performance validating the p2 results, would the FDA not use a little common sense here and allow approval? Considering all data at once, we've essentially run two phase 3s, have excellent results in one,.....and may have great Bavi results in another with a freakish control arm as the only detractor.

[hutschi]

Who bought? Maybe Dart or AZ or The Family or shorts bought back too.

[Bungler]

CP the fact pattern here is the same as it has been for as long as I can recall since 2008 when I first became a shareholder. A run-up in the share price a few days prior to the quarterly conference call, followed by a smackdown on the day of the conference call. And an integral part of this non-wavering fact pattern is the accompanying speculation that this short term rise in share price signals that "someone must know something is going to happen." It is truly amazing how traders are able to play this scenario over and over and over again every quarter and profit from it.

[lemmy]

Despite the saying "for every seller, there's a buyer", stocks still end up on the OTC or Pink Sheets.